|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
The minor allele of two SNPs, one in chromosome region 1q32 SNP (rs11584383), and one in the gene coding for <i>IL23R</i> (rs11209026) conferred protection against AS.
|
29967744 |
2018 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
We replicated associations between AS and the polymorphisms in TNF (rs1800629), TNFRSF1A (rs4149570), and IL23R (rs11209026).
|
30208882 |
2018 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
The results indicate that the nine SNPs (rs11209026, rs1004819, rs10489629, rs11465804, rs1343151, rs11209032, rs1495965, rs7517847, rs2201841) of IL-23R are associated with AS susceptibility in all study subjects in the allelic model.
|
30322951 |
2018 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
Haplotype and conditional analysis of 4230 historical AS cases and 9700 controls revealed a possible AS-associated extended haplotype, including the PRE and risk variants at three SNPs (rs11209026, rs11209032 and rs924080), but excluding the rs11578380 risk variant.
|
28381868 |
2017 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
Interestingly, a functional single nucleotide polymorphism (SNP) in the IL-23 receptor gene (IL-23R; rs11209026, 1142 G wild-type A reduced function, Arg381Gln, R381Q) seems to confer a measure of protection against development of inflammatory bowel disease (IBD; Crohn's disease, ulcerative colitis), ankylosing spondylitis, rheumatoid arthritis, psoriasis, thyroiditis, recurrent spontaneous abortion and asthma, suggesting that a perturbation in the IL-23 signaling pathway is likely to be relevant to the pathophysiology of these diseases.
|
27043356 |
2016 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.
|
23749187 |
2013 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
Our study replicated the robust association between rs11209026 and AS in the French population.
|
23818276 |
2013 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
Meta-analysis also revealed a significant association between the two alleles of the rs11209026 and the rs11465804 polymorphisms and the risk of developing AS in Europeans.
|
22089529 |
2012 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|
21743469 |
2011 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
Genome-wide association studies have shown that the IL23R R381Q gene variant protects against psoriasis, Crohn's disease and ankylosing spondylitis.
|
21364948 |
2011 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
GWASDB |
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|
21743469 |
2011 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.
|
20062062 |
2010 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
GWASDB |
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.
|
20062062 |
2010 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
By contrast, the GA heterozygous genotype of rs11209026 variant showed a significant decrease in AS patients compared with controls.
|
19522770 |
2009 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis.
|
18199597 |
2008 |
|
Ankylosing spondylitis
|
|
0.900 |
GeneticVariation
|
BEFREE |
The primary SNP of interest in a previous study of inflammatory bowel disease (IBD) (Arg381Gln; rs11209026) was found to be protective against AS in the Newfoundland population (P=0.04) and in the Toronto population (P=0.04) in single-marker univariate analysis.
|
18383363 |
2008 |